Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

Patients with scleroderma receiving Iloprost as a treatment for severe Raynaud’s phenomenon report a reduction in skin tightness, suggesting that this drug inhibits skin fibrosis. Connective tissue growth factor (CTGF), a recently described profibrotic cytokine, acts downstream and in concert with T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stratton, Richard, Shiwen, Xu, Martini, Giorgia, Holmes, Alan, Leask, Andrew, Haberberger, Thomas, Martin, George R., Black, Carol M., Abraham, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2001
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC203022/
https://ncbi.nlm.nih.gov/pubmed/11457877
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller